63 related articles for article (PubMed ID: 14639700)
1. Adjustment for competing risk in kin-cohort estimation.
Chatterjee N; Hartge P; Wacholder S
Genet Epidemiol; 2003 Dec; 25(4):303-13. PubMed ID: 14639700
[TBL] [Abstract][Full Text] [Related]
2. Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study.
Chatterjee N; Shih J; Hartge P; Brody L; Tucker M; Wacholder S
Genet Epidemiol; 2001 Sep; 21(2):123-38. PubMed ID: 11507721
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of two different models to predict BRCA1 and BRCA2 mutations in a cohort of Danish hereditary breast and/or ovarian cancer families.
Gerdes AM; Cruger DG; Thomassen M; Kruse TA
Clin Genet; 2006 Feb; 69(2):171-8. PubMed ID: 16433698
[TBL] [Abstract][Full Text] [Related]
4. Case-control and case-only designs with genotype and family history data: estimating relative risk, residual familial aggregation, and cumulative risk.
Chatterjee N; Kalaylioglu Z; Shih JH; Gail MH
Biometrics; 2006 Mar; 62(1):36-48. PubMed ID: 16542227
[TBL] [Abstract][Full Text] [Related]
5. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
Egeli U; Cecener G; Tunca B; Tasdelen I
Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
[TBL] [Abstract][Full Text] [Related]
6. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.
Simchoni S; Friedman E; Kaufman B; Gershoni-Baruch R; Orr-Urtreger A; Kedar-Barnes I; Shiri-Sverdlov R; Dagan E; Tsabari S; Shohat M; Catane R; King MC; Lahad A; Levy-Lahad E
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3770-4. PubMed ID: 16537453
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
8. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
[TBL] [Abstract][Full Text] [Related]
9. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
Eisen A; Lubinski J; Klijn J; Moller P; Lynch HT; Offit K; Weber B; Rebbeck T; Neuhausen SL; Ghadirian P; Foulkes WD; Gershoni-Baruch R; Friedman E; Rennert G; Wagner T; Isaacs C; Kim-Sing C; Ainsworth P; Sun P; Narod SA
J Clin Oncol; 2005 Oct; 23(30):7491-6. PubMed ID: 16234515
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.
Palma M; Ristori E; Ricevuto E; Giannini G; Gulino A
Crit Rev Oncol Hematol; 2006 Jan; 57(1):1-23. PubMed ID: 16337408
[TBL] [Abstract][Full Text] [Related]
12. Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
Oros KK; Ghadirian P; Maugard CM; Perret C; Paredes Y; Mes-Masson AM; Foulkes WD; Provencher D; Tonin PN
Clin Genet; 2006 Oct; 70(4):320-9. PubMed ID: 16965326
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations.
Ahn SH; Son BH; Yoon KS; Noh DY; Han W; Kim SW; Lee ES; Park HL; Hong YJ; Choi JJ; Moon SY; Kim MJ; Kim KH; Kwak BS; Cho DY
Cancer Lett; 2007 Jan; 245(1-2):90-5. PubMed ID: 16455195
[TBL] [Abstract][Full Text] [Related]
14. Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers.
Kroiss R; Winkler V; Bikas D; Fleischmann E; Mainau C; Frommlet F; Muhr D; Fuerhauser C; Tea M; Bittner B; Kubista E; Oefner PJ; Bauer P; Wagner TM;
Hum Mutat; 2005 Dec; 26(6):583-9. PubMed ID: 16287141
[TBL] [Abstract][Full Text] [Related]
15. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
van Asperen CJ; Brohet RM; Meijers-Heijboer EJ; Hoogerbrugge N; Verhoef S; Vasen HF; Ausems MG; Menko FH; Gomez Garcia EB; Klijn JG; Hogervorst FB; van Houwelingen JC; van't Veer LJ; Rookus MA; van Leeuwen FE;
J Med Genet; 2005 Sep; 42(9):711-9. PubMed ID: 16141007
[TBL] [Abstract][Full Text] [Related]
16. Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.
Evans DG; Young K; Bulman M; Shenton A; Wallace A; Lalloo F
Clin Genet; 2008 Apr; 73(4):338-45. PubMed ID: 18312450
[TBL] [Abstract][Full Text] [Related]
17. Pseudo-likelihood estimates of the cumulative risk of an autosomal dominant disease from a kin-cohort study.
Moore DF; Chatterjee N; Pee D; Gail MH
Genet Epidemiol; 2001 Feb; 20(2):210-27. PubMed ID: 11180447
[TBL] [Abstract][Full Text] [Related]
18. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
19. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BRCA2 mutations in a South American population.
Jara L; Ampuero S; Santibáñez E; Seccia L; Rodríguez J; Bustamante M; Martínez V; Catenaccio A; Lay-Son G; Blanco R; Reyes JM
Cancer Genet Cytogenet; 2006 Apr; 166(1):36-45. PubMed ID: 16616110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
